Комбинированная терапия лефлуномидом и генно-инженерными биологическими препаратами
https://doi.org/10.14412/1996-7012-2011-668
Аннотация
Ключевые слова
Об авторах
Наталья Владимировна ЧичасоваЕвгений Львович Насонов
Наталья Владимировна Чичасова
Евгений Львович Насонов
Литература
1. <div><p>. Breedveld F.C., Weisman M.H., Kavanaugh A.F. et al. A multicenter, randomized, double-blind clinical trial of combination therapy with Adalimumab plus methotrexate versus methotrexate alone or Adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthr Rheum 2006; 54: 26-37.</p><p>Furst D.E., Keystone E.C., Kirkham B. et al. Update consensus statement on biological agents for the treatment of rheumatic diseases, 2008. Ann Rheum Dis 2008.67(Suppl. III): iii2-iii25.</p><p>Elkaym O., Yaron I., Shirazi I. et al. Active leflunomide metabolite inhibits interleukin 1 beta, tumor necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann Rheum Dis 2003; 62(5): 440-3.</p><p>Cuoto M., Sulli A., Ghiorzo P. et al. Antiinflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. Ann Rheum Dis 2003; 62(4): 297-302.</p><p>Cutolo M., Sulli A., Ghiorzo C. et al. Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patient with rheumatoid arthritis. Ann Rheum Dis 2003; 62(4): 297-302.</p><p>Bingham S.J., Buch M.H., Kerr M.A. et al. Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide. Arthr Rheum 2004; 50(12): 4072-3.</p><p>Kalden J.R., Antoni C., Alvaro-Gracia J.M. et al. Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritis. J Rheum 2005; 32(8): 1620-31.</p><p>Hansen R.E., Cush J., Singhal G.F. Safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis. Arthr Rheum 2004; 51(2): 228-32.</p><p>Pedriger A., Combe B., Kuntz J.L. et al. French multicenter retrospective study of the efficacy and safety of infliximab in association with DMARD's other than methotrexate (abstract). Ann Rheum Dis 2004; 50(Suppl.): 488.</p><p>Ortiz Garcia A.M., Gonsales-Alvaro I., Rosello Pardo R. et al. Infliximab and Leflunomide Study Group. Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis [letter]. Clin Exp Rheum 2004; 22: 790.</p><p>Kiely P.D., Johnson L.M. Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study. Rheum (Oxford) 2002; 41(6): 631-7.</p><p>Antoni C., Manger B. Treatment of rheumatoid arthritis with TNF alpha-antagonist. Z Rheum 2003; 62(3): 235-9.</p><p>Flendrie M., Creemers M.C., Welsing P.M. et al. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis: a longitudinal observation study. Rheum (Oxford) 2005; 44(5): 472-8.</p><p>Antanassioni C. Efficacy and safety of combination leflunomide and infliximab in patients with refractory rheumatoid arthritis. Arthr Rheum 2005; 51(Suppl.): S.76-7.</p><p>Patel S., Bergen W., Kraemer A. et al. Efficacy and safety of remicade (infliximab) plus arava (leflunomide) in rheumatoid arthritis (RA) [abstr.]. Arthr Rheum 2001; 44(Suppl.): S.84.</p><p>Godinho F., Godfrin B. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis. Clin Exp Rheum 2004; 22(3): 328-30.</p><p>Finckh A., Dehler S., Gabay C. Effectiveness of leflunomide as co-therapy of TNF inhibitors in rheumatoid arthritis. A population based study. Ann Rheum Dis 2008; 69: 136-41.</p><p>Van Riel P. Insights from Dutch DMARD and biological registries. In: Rheumatoid arthritis: optimizing management trough education. Abstr. Book, 17-18 March 2007, Vienna, Austria; p. 16-17.</p><p>Mariette X., Bijlsma J.W.J., Herold M. et al. Efficacy evaluation of Adalimumab (Humira) in combination with single and multiple disease modifying antirheumatic drugs in the REACT trial. Pres. At The Annual European Congress of Rheumatology EULAR 2004. Ann Rheum Dis 2005; 64(Suppl. 3): 424, SAT0048.</p><p>Furst D.E., Schiff M.H., Fleischmann R.M. et al. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheum 2003; 30: 2563-71.</p><p>Van Vollenhoven R.F., Emery P., Bingham III C.O. et al. Long-term safety of rituximab: 6-year follow-up of the RA clinical trial and re-treatment population. Arthr Rheum 2008; 58(Suppl. 9): s300.</p><p>Vital E.M., Dass S., Rawstron A.C. et al. Combination rituximab and leflunomide produces lasting responses in rheumatoid arthritis. Ann Rheum Dis 2008; 67(Suppl. II): 90.</p><p>Henes J., Schedel J., Kanz L. et al. Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis. Rheum Int 2010; 30(5): 709-12.</p><p>Насонов Е.Л., Лукина Г.В., Сигидин Я.А. Комбинированная терапия ритуксимабом и лефлуномидом при ревматоидном артрите (предварительные результаты российского регистра АРБИТР). Науч.-практич. ревматол. 2011; 1: 16-20.</p><p>Genovese M., McKay J., Nasonov E. et al. Interleukin-6 receptor inhibition with tozilisumab reduced disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs. Arthr Rheum 2008; 58: 2968-80.</p><p>Smolen J.S. Practical management of rheumatoid arthritis patients treated with leflunomide. An international expert panel meeting. J Rheum 2004; 71(Suppl.): 1 - 12.</p></div><br />
Рецензия
Для цитирования:
Чичасова НВ, Насонов ЕЛ, Чичасова НВ, Насонов ЕЛ. Комбинированная терапия лефлуномидом и генно-инженерными биологическими препаратами. Современная ревматология. 2011;5(2):43-49. https://doi.org/10.14412/1996-7012-2011-668
For citation:
Chichasova NV, Nasonov EL, Chichasova NV, Nasonov EL. Combination therapy with leflunomide and genetic engineering biological agents. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2011;5(2):43-49. https://doi.org/10.14412/1996-7012-2011-668
Послать статью по эл. почте 